Italia markets close in 11 minutes

BMY Nov 2025 25.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,60000,0000 (0,00%)
In data: 10:54AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,6000
Aperto0,6000
Denaro0,4800
Domanda0,5500
Prezzo d'esercizio25,00
Scadenza2025-11-21
Min-Max giorno0,6000 - 0,6000
Contratto - Min-MaxN/D
Volume5
Open Interest752
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri